Table 6 KEGG pathway analysis of DEGs expressed only in group SA, not in other groups
Pathway ID | Pathway | DEGs with pathway annotation (293) | P-value |
|---|---|---|---|
ko00240 | Pyrimidine metabolism | 10(3.41%) | 8.46E-04 |
ko05144 | Malaria | 9(3.07%) | 1.24E-05 |
ko00760 | Nicotinate and nicotinamide metabolism | 7(2.39%) | 5.73E-04 |
ko05340 | Primary immunodeficiency | 5(1.71%) | 1.27E-03 |
ko00500 | Starch and sucrose metabolism | 5(1.71%) | 1.13E-03 |
ko00521 | Streptomycin biosynthesis | 4(1.37%) | 5.95E-05 |
ko00640 | Propanoate metabolism | 4(1.37%) | 1.29E-03 |
ko01210 | 2-Oxocarboxylic acid metabolism | 4(1.37%) | 4.26E-04 |
ko00524 | Neomycin, kanamycin and gentamicin biosynthesis | 3(1.02%) | 4.86E-05 |
ko00770 | Pantothenate and CoA biosynthesis | 3(1.02%) | 1.90E-03 |
ko00254 | Aflatoxin biosynthesis | 2(0.68%) | 1.14E-03 |
ko00363 | Bisphenol degradation | 1(0.34%) | 0.00E+ 00 |
ko02026 | Biofilm formation - Escherichia coli | 1(0.34%) | 1.03E-03 |